Literature DB >> 14970340

Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.

Cristina Casalone1, Gianluigi Zanusso, Pierluigi Acutis, Sergio Ferrari, Lorenzo Capucci, Fabrizio Tagliavini, Salvatore Monaco, Maria Caramelli.   

Abstract

Transmissible spongiform encephalopathies (TSEs), or prion diseases, are mammalian neurodegenerative disorders characterized by a posttranslational conversion and brain accumulation of an insoluble, protease-resistant isoform (PrP(Sc)) of the host-encoded cellular prion protein (PrP(C)). Human and animal TSE agents exist as different phenotypes that can be biochemically differentiated on the basis of the molecular mass of the protease-resistant PrP(Sc) fragments and the degree of glycosylation. Epidemiological, molecular, and transmission studies strongly suggest that the single strain of agent responsible for bovine spongiform encephalopathy (BSE) has infected humans, causing variant Creutzfeldt-Jakob disease. The unprecedented biological properties of the BSE agent, which circumvents the so-called "species barrier" between cattle and humans and adapts to different mammalian species, has raised considerable concern for human health. To date, it is unknown whether more than one strain might be responsible for cattle TSE or whether the BSE agent undergoes phenotypic variation after natural transmission. Here we provide evidence of a second cattle TSE. The disorder was pathologically characterized by the presence of PrP-immunopositive amyloid plaques, as opposed to the lack of amyloid deposition in typical BSE cases, and by a different pattern of regional distribution and topology of brain PrP(Sc) accumulation. In addition, Western blot analysis showed a PrP(Sc) type with predominance of the low molecular mass glycoform and a protease-resistant fragment of lower molecular mass than BSE-PrP(Sc). Strikingly, the molecular signature of this previously undescribed bovine PrP(Sc) was similar to that encountered in a distinct subtype of sporadic Creutzfeldt-Jakob disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14970340      PMCID: PMC365745          DOI: 10.1073/pnas.0305777101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease.

Authors:  Gianluigi Zanusso; Sergio Ferrari; Franco Cardone; Paolo Zampieri; Matteo Gelati; Michele Fiorini; Alessia Farinazzo; Marina Gardiman; Tiziana Cavallaro; Marina Bentivoglio; Pier Giorgio Righetti; Maurizio Pocchiari; Nicola Rizzuto; Salvatore Monaco
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

2.  Unconventional viruses and the origin and disappearance of kuru.

Authors:  D C Gajdusek
Journal:  Science       Date:  1977-09-02       Impact factor: 47.728

3.  Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.

Authors:  Carsten Korth; Kiyotoshi Kaneko; Darlene Groth; Norbert Heye; Glenn Telling; James Mastrianni; Piero Parchi; Pierluigi Gambetti; Robert Will; James Ironside; Cornelia Heinrich; Patrick Tremblay; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

4.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.

Authors:  M R Scott; R Will; J Ironside; H O Nguyen; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee.

Authors:  C J Gibbs; D C Gajdusek; D M Asher; M P Alpers; E Beck; P M Daniel; W B Matthews
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

6.  pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease.

Authors:  G Zanusso; A Farinazzo; M Fiorini; M Gelati; A Castagna; P G Righetti; N Rizzuto; S Monaco
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

7.  Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis.

Authors:  P Brown; P Rodgers-Johnson; F Cathala; C J Gibbs; D C Gajdusek
Journal:  Ann Neurol       Date:  1984-09       Impact factor: 10.422

8.  Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

Authors:  P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

Review 9.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

10.  BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.

Authors:  Emmanuel A Asante; Jacqueline M Linehan; Melanie Desbruslais; Susan Joiner; Ian Gowland; Andrew L Wood; Julie Welch; Andrew F Hill; Sarah E Lloyd; Jonathan D F Wadsworth; John Collinge
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

View more
  140 in total

1.  Concern about mad cow disease: end of the beginning, or beginning of the end?

Authors:  Herbert Budka
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

2.  PRNP and SPRN genes polymorphism in atypical bovine spongiform encephalopathy cases diagnosed in Polish cattle.

Authors:  Artur Gurgul; Mirosław Paweł Polak; Magdalena Larska; Ewa Słota
Journal:  J Appl Genet       Date:  2012-06-22       Impact factor: 3.240

3.  The Croonian Lecture 2004 risk: food, fact and fantasy.

Authors:  John R Krebs
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-06-29       Impact factor: 6.237

4.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

5.  Atypical H-type bovine spongiform encephalopathy in a cow born after the reinforced feed ban on meat-and-bone meal in Europe.

Authors:  Claudia Guldimann; Michaela Gsponer; Cord Drögemüller; Anna Oevermann; Torsten Seuberlich
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

Review 6.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

7.  Biochemical typing of pathological prion protein in aging cattle with BSE.

Authors:  Seraina Tester; Valerie Juillerat; Marcus G Doherr; Bianca Haase; Miroslaw Polak; Felix Ehrensperger; Tosso Leeb; Andreas Zurbriggen; Torsten Seuberlich
Journal:  Virol J       Date:  2009-05-26       Impact factor: 4.099

8.  Species and strain glycosylation patterns of PrPSc.

Authors:  Konstantinos Xanthopoulos; Magdalini Polymenidou; Sue J Bellworthy; Sylvie L Benestad; Theodoros Sklaviadis
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

9.  Atypical bovine spongiform encephalopathies, France, 2001-2007.

Authors:  Anne-Gaëlle Biacabe; Eric Morignat; Johann Vulin; Didier Calavas; Thierry G M Baron
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  No H- and L-type cases in Belgium in cattle diagnosed with bovine spongiform encephalopathy (1999-2008) aging seven years and older.

Authors:  Alexandre Dobly; Jan Langeveld; Lucien van Keulen; Caroline Rodeghiero; Stéphanie Durand; Riet Geeroms; Patrick Van Muylem; Jessica De Sloovere; Emmanuel Vanopdenbosch; Stefan Roels
Journal:  BMC Vet Res       Date:  2010-05-21       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.